Effect of Coronavirus Treatment Protocol on Metabolic Factors of Plasma

Investigating the Effect of National Protocol for Treatment of Covid-19 Disease on Amino Acids, Carnitines and Acylcarnitine's Profile of Plasma in Hospitalized Patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151227025726N35

Enrollment

Registered

2023-10-18

Start date

2023-11-15

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 pneumonia. COVID-19, virus identified

Interventions

Intervention group: From 30 patients receiving the national protocol for treatment of Covid-19 disease, blood samples is taken on Guthrie Whatman 903 paper on the third day of hospitalization.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with positive PCR test Patients with moderate to severe pulmonary involvement Patients with respiratory rate less than or equal to 30 breaths per minute Patients with percentage of saturated oxygen less than or equal to 94

Exclusion criteria

Exclusion criteria: Patients with mechanical ventilation Patients with psychotic disorders

Design outcomes

Primary

Measure	Time frame
Plasma concentrations of amino acids, carnitines and acylcarnitine's. Timepoint: On the third day of hospitalization. Method of measurement: Liquid chromatography-Mass spectrometry.	—

Secondary

Measure	Time frame
Adverse drug reaction. Timepoint: At the end of the study. Method of measurement: Medical record.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Dastan

Shahid Beheshti University of Medical Sciences

f_dastan@sbmu.ac.ir+98 21 8887 3704

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026